These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


169 related items for PubMed ID: 9596394

  • 1. Low-dose botulinum toxin with ankle taping for the treatment of spastic equinovarus foot after stroke.
    Reiter F, Danni M, Lagalla G, Ceravolo G, Provinciali L.
    Arch Phys Med Rehabil; 1998 May; 79(5):532-5. PubMed ID: 9596394
    [Abstract] [Full Text] [Related]

  • 2. Combined effects of robot‑assisted gait training and botulinum toxin type A on spastic equinus foot in patients with chronic stroke: a pilot, single blind, randomized controlled trial.
    Picelli A, Bacciga M, Melotti C, LA Marchina E, Verzini E, Ferrari F, Pontillo A, Corradi J, Tamburin S, Saltuari L, Corradini C, Waldner A, Smania N.
    Eur J Phys Rehabil Med; 2016 Dec; 52(6):759-766. PubMed ID: 27098300
    [Abstract] [Full Text] [Related]

  • 3. A single-blinded, randomized pilot study of botulinum toxin type A combined with non-pharmacological treatment for spastic foot.
    Baricich A, Carda S, Bertoni M, Maderna L, Cisari C.
    J Rehabil Med; 2008 Nov; 40(10):870-2. PubMed ID: 19242626
    [Abstract] [Full Text] [Related]

  • 4. Botulinum Toxin Type A Injection for Spastic Equinovarus Foot in Children with Spastic Cerebral Palsy: Effects on Gait and Foot Pressure Distribution.
    Choi JY, Jung S, Rha DW, Park ES.
    Yonsei Med J; 2016 Mar; 57(2):496-504. PubMed ID: 26847306
    [Abstract] [Full Text] [Related]

  • 5. Adhesive taping vs. daily manual muscle stretching and splinting after botulinum toxin type A injection for wrist and fingers spastic overactivity in stroke patients: a randomized controlled trial.
    Santamato A, Micello MF, Panza F, Fortunato F, Picelli A, Smania N, Logroscino G, Fiore P, Ranieri M.
    Clin Rehabil; 2015 Jan; 29(1):50-8. PubMed ID: 24917588
    [Abstract] [Full Text] [Related]

  • 6. Low-dose botulinum toxin with short-term electrical stimulation in poststroke spastic drop foot: a preliminary study.
    Bayram S, Sivrioglu K, Karli N, Ozcan O.
    Am J Phys Med Rehabil; 2006 Jan; 85(1):75-81. PubMed ID: 16357552
    [Abstract] [Full Text] [Related]

  • 7. Outcomes of Botulinum Toxin Type A for equinovarus deformity in patients with CVA: A case series.
    Karakkattil P, Trudelle-Jackson E, Brown HH, Hammontree P, Okolo M.
    Physiother Theory Pract; 2017 May; 33(5):410-419. PubMed ID: 28481738
    [Abstract] [Full Text] [Related]

  • 8. Ankle muscle activity before and after botulinum toxin therapy for lower limb extensor spasticity in chronic hemiparetic patients.
    Hesse S, Krajnik J, Luecke D, Jahnke MT, Gregoric M, Mauritz KH.
    Stroke; 1996 Mar; 27(3):455-60. PubMed ID: 8610313
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Casting, taping or stretching after botulinum toxin type A for spastic equinus foot: a single-blind randomized trial on adult stroke patients.
    Carda S, Invernizzi M, Baricich A, Cisari C.
    Clin Rehabil; 2011 Dec; 25(12):1119-27. PubMed ID: 21729974
    [Abstract] [Full Text] [Related]

  • 11. Effects of botulinum toxin-A on gait velocity, step length, and base of support of patients with dynamic equinovarus foot.
    Cioni M, Esquenazi A, Hirai B.
    Am J Phys Med Rehabil; 2006 Jul; 85(7):600-6. PubMed ID: 16788391
    [Abstract] [Full Text] [Related]

  • 12. Local botulinum toxin in the treatment of spastic drop foot.
    Dengler R, Neyer U, Wohlfarth K, Bettig U, Janzik HH.
    J Neurol; 1992 Aug; 239(7):375-8. PubMed ID: 1403018
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic nerve block in prediction of outcome of botulinum toxin treatment for spastic equinovarus foot after stroke: A retrospective observational study.
    Picelli A, Battistuzzi E, Filippetti M, Modenese A, Gandolfi M, Munari D, Smania N.
    J Rehabil Med; 2020 Jun 12; 52(6):jrm00069. PubMed ID: 32432331
    [Abstract] [Full Text] [Related]

  • 14. Botulinum toxin treatment for lower limb extensor spasticity in chronic hemiparetic patients.
    Hesse S, Lücke D, Malezic M, Bertelt C, Friedrich H, Gregoric M, Mauritz KH.
    J Neurol Neurosurg Psychiatry; 1994 Nov 12; 57(11):1321-4. PubMed ID: 7964805
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of therapeutic ultrasound and transcutaneous electrical nerve stimulation compared with botulinum toxin type A in the treatment of spastic equinus in adults with chronic stroke: a pilot randomized controlled trial.
    Picelli A, Dambruoso F, Bronzato M, Barausse M, Gandolfi M, Smania N.
    Top Stroke Rehabil; 2014 Nov 12; 21 Suppl 1():S8-16. PubMed ID: 24722047
    [Abstract] [Full Text] [Related]

  • 16. Comparing soleus injections and gastrocnemius injections of botulinum toxin for treating adult spastic foot drop: a monocentric observational study.
    Hefter H, Nickels W, Samadzadeh S, Rosenthal D.
    J Int Med Res; 2021 Mar 12; 49(3):300060521998208. PubMed ID: 33784844
    [Abstract] [Full Text] [Related]

  • 17. Comparison between tibial nerve block with anaesthetics and neurotomy in hemiplegic adults with spastic equinovarus foot.
    Deltombe T, Bleyenheuft C, Gustin T.
    Ann Phys Rehabil Med; 2015 Apr 12; 58(2):54-9. PubMed ID: 25614022
    [Abstract] [Full Text] [Related]

  • 18. Variability and predictability of functional efficacy of botulinum toxin injection in leg spastic muscles.
    Rousseaux M, Compère S, Launay MJ, Kozlowski O.
    J Neurol Sci; 2005 May 15; 232(1-2):51-7. PubMed ID: 15850582
    [Abstract] [Full Text] [Related]

  • 19. A pilot study to investigate the combined use of Botulinum toxin type-a and ankle foot orthosis for the treatment of spastic foot in chronic hemiplegic patients.
    Pradon D, Hutin E, Khadir S, Taiar R, Genet F, Roche N.
    Clin Biomech (Bristol); 2011 Oct 15; 26(8):867-72. PubMed ID: 21592635
    [Abstract] [Full Text] [Related]

  • 20. Ankle and Foot Spasticity Patterns in Chronic Stroke Survivors with Abnormal Gait.
    Li S.
    Toxins (Basel); 2020 Oct 07; 12(10):. PubMed ID: 33036356
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.